Nano Cap Podcast

In this engaging interview, Scott Maskin, CEO of SUNation Energy, shares his journey from the music industry to renewable energy. Discover the evolution of solar technology, innovative business models, and the future of decentralized energy solutions.SUNation Energy Website: https://www.sunation.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, we explore the innovative world of drone technology with Linda Montgomery and James Sherman from ZenaTech. Discover how their company is transforming industries like land surveying, defense, and logistics through AI, quantum computing, and drone-as-a-service solutions.ZenaTech Website: https://www.zenatech.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Lavell , CEO of Brag House, shares insights on building a media tech platform at the intersection of gaming, college sports, and social media. He discusses the journey from law to entrepreneurship, the strategic decision to go public, and the future of engaging Gen Z through gamification and data-driven insights.Brag House Website: https://www.braghouse.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Jay File, CEO of Lite Strategy, joins the Nano Cap Podcast to discuss how the company is approaching Litecoin as a treasury reserve asset and why it believes Litecoin has a unique role to play in the broader digital asset market.The conversation covers Lite Strategy’s investment thesis, its strategy for building exposure to Litecoin, and how the company thinks about risk, liquidity, volatility, and long-term value creation. Jay also shares his perspective on Litecoin’s utility as a fast, low-cost, globally accessible payment network, and why it may continue to gain relevance as digital assets become more integrated into financial markets.The episode also explores the future of Litecoin’s ecosystem, including potential growth in transactions, adoption, institutional interest, and real-world use cases. Jay discusses where he sees the biggest opportunities ahead for Lite Strategy, how the company differentiates itself from other digital asset treasury models, and what investors should understand about Litecoin’s place in the evolving crypto landscape.Lite Strategy: https://litestrategy.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Alex Yang, CEO of Polaryx Therapeutics, shares his journey from law to biotech, the innovative science behind lysosomal storage disorder treatments, and the strategic advantages of platform trials and regulatory designations. Discover how Polaryx is pioneering therapies for rare pediatric diseases with a focus on ethical, scientific, and investment perspectives.Polaryx Therapeutics Website: https://polaryx.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Lance Alstodt, CEO of BioRestorative Therapies, talks about their innovative stem cell therapies targeting chronic pain and metabolic disorders. They discuss the company's technology, clinical trials, market potential, and future plans, providing insights into regenerative medicine and biotech investment strategies.BioRestorative Therapies - https://biorestorative.com/Nano Cap Pod Website - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this insightful interview, Alex McDougall, CEO of FUTR Corp, explores the intersection of AI, blockchain, and data sovereignty. Discover how their innovative platform acts on your behalf, protects your data, and rewards you for sharing information, revolutionizing personal data management and AI utility.FUTR Corp Website - https://thefutrcorp.com/Nano Cap Podcast Website - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This week, I speak with Chris Burns, CEO of Amplia Therapeutics, a biotech company developing a promising FAK inhibitor for cancer treatment. Discover the science behind their approach, recent progress in clinical trials, and the vision for transforming pancreatic cancer outcomes.Key Topics:The science behind FAK inhibitors and their role in modulating tumor microenvironmentsHow Amplia's Narmaphonib improves efficacy, durability, and tolerability of pancreatic cancer treatmentsStrategic focus on FDA approval pathway and ongoing clinical trials in the US and AustraliaThe significance of combination therapies in overcoming resistance and enhancing effectivenessThe future potential of FAK inhibitors in treating other solid tumors like ovarian and lung cancerChris Burns' journey from academic research in Australia to biotech leadership and innovationAmplia Therapeutics Website: https://ampliatx.com/Nano Cap Podcast Website https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This week I interview Ed Gillespie, CEO of Abundia Global Impact Group. He shares insights into transforming waste plastics into renewable fuels, the journey of going public, and the vision for scalable green tech solutions. This episode reveals how industry challenges and opportunities align to create a sustainable future.Main Topics Covered:Ed Gillespie’s background and entrepreneurial journey from Ireland to the USThe genesis and growth of Abundia Global Impact GroupThe waste-to-value technology: pyrolysis and upgradation to biofuelsStrategic decisions behind going public and capital deploymentThe significance of siting in Baytown, Texas, and industry culture differencesMarket potential for converting plastic waste into jet fuel and other productsFuture expansion plans: multiple facilities and global market considerationsRole of government support and industry mandates in promoting recycling techThe importance of technological validation and scaling in green tech venturesAbundia's Website - https://abundiaimpact.com/Nano Cap Podcast - https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Bill Wentworth, CEO of Data I/O, shares his extensive background in the tech industry, detailing his journey from working in electronics distribution to leading Data I/O through significant industry changes. He discusses the impact of AI on the tech landscape, the importance of leveraging institutional knowledge, and his vision for the future of Data I/O, emphasizing growth through diversification and innovation.Data IO Website: https://www.dataio.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund Interviews Jan Goetgeluk the CEO and founder of Virtuix. Jan talks about how he turned a mechanical engineering background into a groundbreaking VR product. From prototypes to NASDAQ listing, learn the story behind the Omni omnidirectional treadmill transforming gaming, training, and defense sectors.In this episode:The origin story of Virtuix and the inception of the Omni treadmillHow VR technology evolved from Palmer Lucky and Oculus influencesThe mechanical design principles behind a compact, affordable omnidirectional treadmillThe role of AI in enabling rapid virtual environment reconstructionVertuix’s dual-use strategy targeting both consumer gaming and defense marketsThe health benefits and fitness impact of VR treadmill gamingFuture plans: international expansion and new application marketsTimestamps:00:00 - Introduction to Jan Goetgeluk and Vertuix's innovative VR treadmill01:14 - Jan’s journey from Belgium to US entrepreneurship01:39 - Deciding to stay in the US and move from banking to startups02:09 - How a mechanical engineering degree fueled a VR mechanical solution02:50 - The significance of Oculus and Palmer Lucky’s early influence03:14 - Why walking naturally in VR was the missing piece in current tech03:54 - Developing the first prototype after hours and the Kickstarter journey04:34 - The breakthrough with the second prototype and viral video of Skyrim in VR05:22 - Reaching out to VC and community support for funding06:20 - The impact of Oculus Kickstarter success on Vertuix’s campaign06:58 - What is the Omni treadmill and its core features07:47 - Growth, recent product launches, and company milestones08:03 - Overcoming mechanical design challenges for smooth and natural walking08:40 - Protecting the mechanical IP with patents and innovations09:31 - How environment mapping and AI enable quick virtual world creation10:04 - Applying VR in defense for terrain familiarization and training11:28 - The dual-use strategy combining gaming with defense contracts12:38 - Balancing consumer scaling with defense applications13:45 - Exploring large B2B opportunities like entertainment centers and theme parks15:12 - Price points aligned with high-end gaming setups16:16 - The health benefits and calorie-burning advantages, with real user examples17:25 - Future plans: international expansion and new markets17:50 - Potential licensing and patent protections19:03 - Jan’s motivation and vision for the next decade19:47 - How to learn more and connect with VertuixResources & Links:Virtuix Official WebsiteNASADAQ Ticker VTIXNano Cap Podcast WebsiteDISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this week's episode, Dr. Lynn Kirkpatrick, CEO of Encyse Biosciences, discusses her journey from academia to entrepreneurship, focusing on innovative solutions for opioid delivery. She highlights the unique approach of her company in developing a safer opioid alternative, the challenges faced in the pharmaceutical industry, and her vision for improving pain management for patients.Ensysce Biosciences Website: https://ensysce.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund interviews Greg Feller, the president and co-founder of Orion Digital Corp, a financial technology company focused on creating intelligent financial systems. Greg shares insights from his entrepreneurial journey, starting from his college days with his brother, where they first explored business ideas. He discusses his early career on Wall Street, including experiences at Lehman Brothers and Goldman Sachs during pivotal moments in financial history, such as the dot-com boom and the global financial crisis. Greg emphasizes the importance of learning from these experiences and how they shaped the vision for Orion Digital. Greg elaborates on Orion Digital's mission to provide a unique wealth management platform that prioritizes long-term investment strategies over the quick gains often promoted by other trading apps. He highlights the company's innovative approach to intelligent investing, which is designed to help users make informed financial decisions while avoiding the pitfalls of impulsive trading. The conversation also touches on the company's expansion into payment processing and the potential of stablecoins, showcasing Greg's forward-thinking perspective on the evolving financial landscape.Orion Digital Website https://www.orion-digital.com/Nano Cap Podcast Website https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Jay Jackson, CEO of Abacus Global Management, discusses the evolution of life insurance as an investment vehicle, the importance of treating life insurance as personal property, and the role of data and technology in predicting mortality. He emphasizes the significance of AI in transforming the insurance industry and shares insights on balancing innovation with revenue generation. The discussion highlights the value of lifespan and the purpose behind their business in providing financial solutions.Abacus Global Management Website: https://abacusgm.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Vin Singh, CEO of Bullfrog AI, discusses his journey from founding Maxite to leading Bullfrog AI, a company focused on using AI for drug discovery. He shares insights on the challenges in drug development, the importance of proprietary data, and the company's partnerships that have led to significant discoveries in neuropsychiatric disorders. Vin emphasizes the mission of saving lives through technology and outlines the go-to-market strategy for Bullfrog AI.BullfrogAI website: https://bullfrogai.com/Nano Cap Pod Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Greg Duncan, CEO of Dogwood Therapeutics, discusses his extensive career in the biotech industry, the formation of Dogwood Therapeutics, and the innovative non-opioid pain management solution, Halneuron. He elaborates on the clinical trials for Halneuron, its potential applications, and the company's focus on addressing pain and neuropathy associated with chemotherapy. Additionally, Duncan shares insights into other therapeutic avenues being explored by Dogwood, including treatments for fibromyalgia and long COVID, and emphasizes the importance of improving patient quality of life.Dogwood Therapeutics Website: https://www.dwtx.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, David Moss, CEO of INmune Bio, discusses his journey in the biotech industry, the founding of INmune Bio, and the company's focus on modulating the innate immune system to develop therapies for diseases like Alzheimer's and rare pediatric conditions. He emphasizes the importance of scientific integrity in research and the challenges faced in the Alzheimer's space, while also sharing his personal motivations for driving the company's mission forward.TakeawaysDavid Moss has a long-standing passion for biotech, influenced by family connections.INmune Bio focuses on the innate immune system, which is often overlooked in drug development.The company was founded to create affordable therapies for complex diseases.Their product platforms include Chordstrom for rare diseases and Expro for Alzheimer's.Alzheimer's disease represents a significant unmet medical need with millions affected.Recruiting patients for clinical trials is a structured process, not a marketing campaign.David's personal connection to Alzheimer's motivates his work at INmune Bio.The company aims to disrupt chronic inflammation to improve cognitive function.Expro is designed to be a lifelong treatment for Alzheimer's patients.INmune Bio is open to discussions with investors and interested parties.INmune Bio website: https://www.inmunebio.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Andrew Brodkey, CEO of Idaho Copper, discusses his unique background in mining and law, the evolution of the mining industry, and the specifics of the CuMo project. He highlights the importance of responsible mining practices, the dynamics of copper pricing, and the innovative ore sorting technology that could enhance the project's economic viability. Brodkey also addresses the challenges faced in the mining sector, including regulatory hurdles and supply chain dynamics, while expressing optimism about the future of Idaho Copper and the demand for critical minerals.Idaho Copper Website - https://www.idaho-copper.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Dr. Joseph Sinkule, CEO of Klotho Neurosciences, discusses his extensive background in medical research and entrepreneurship, focusing on the development of innovative therapies for age-related cognitive and neurodegenerative disorders. He explains the significance of the Klotho protein, its potential in gene therapy, and the company's strategic approach to addressing diseases like Alzheimer's and ALS. The discussion also touches on the importance of diagnostics and the future vision for extending healthy lifespans.Klotho Neurosciences website: https://klothoneuro.com/Episode NotesDr. Sinkule has transitioned from clinical practice to entrepreneurship over 46 years.Klotho Neurosciences focuses on developing therapies for neurodegenerative diseases.The Klotho protein is linked to anti-aging and cognitive enhancement.Gene therapy using Klotho has potential applications in ALS and Alzheimer's.Diagnostics play a crucial role in identifying candidates for Clotho therapies.The company aims to balance research with practical business strategies.Dr. Sinkule emphasizes the importance of early intervention in neurodegenerative diseases.Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, David Crean, Chief Business Officer of Medici Nova, shares his journey from academia to the biopharmaceutical industry. He discusses his early career, pivotal moments, and the unique business model of MediciNova, which focuses on addressing unmet medical needs in challenging diseases like ALS. Crean emphasizes the importance of capital efficiency in drug development and outlines the exciting projects currently underway at MediciNova, highlighting the potential impact on patients.MediciNova Website - https://medicinova.com/Nano Cap Podcast - https://www.nanocappod.com/Takeaways David Crean transitioned from academia to the biopharmaceutical industry.He values education and holds both a PhD and an MBA.MediciNova focuses on unmet medical needs, particularly in ALS.The company operates with a unique, capital-efficient business model.Crean emphasizes the importance of strategic corporate finance and development.He has a strong interest in drug commercialization and development.MediciNova has a pipeline of promising compounds with existing data.The company is close to finalizing patient enrollment for key trials.Crean is excited about the potential impact of their drugs on patients.DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This Episode, Joseph Pandolfino discusses his journey in the alternative tobacco industry, starting from his discovery of herbal cigarettes to the development of low nicotine products blended with hemp. He shares insights on the challenges and innovations in creating products that cater to smokers looking to reduce their nicotine intake. The discussion also covers the regulatory landscape, patent strategies, and the future of tobacco products in both domestic and international markets.Cabbacis Website https://www.cabbacis.com/Nano Cap Podcast https://www.nanocappod.com/TakeawaysJoseph discovered herbal cigarettes in a health food store.He genetically engineered tobacco to reduce nicotine content.The addition of hemp improved the taste of low nicotine cigarettes.Joseph holds 35 patents related to tobacco and hemp products.The US has stringent regulations for new tobacco products.Cabbacis plans to file a pre-market tobacco application soon.Cigarettes remain the most consumed tobacco product globally.Keeping expenses low is crucial for business sustainability.The management team is compensated with equity, not salary.Cabbacis aims to target English-speaking countries for expansion.DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Ben Hwang, CEO of Profusa, shares his unique journey from working with the Dodgers to leading a company focused on innovative biosensors. He discusses the vision behind Profusa, the challenges of transforming healthcare through technology, and the importance of real-time data in managing chronic diseases. Hwang emphasizes the need for accessible and clinically validated health solutions and outlines the future aspirations of the company in scaling their technology to benefit a wider audience.Profusa Website - https://profusa.com/Nano Cap Podcast Website - https://www.nanocappod.com/TakeawaysBen's early experiences with the Dodgers shaped his career.He transitioned from sports to academia, earning a PhD.Profusa aims to revolutionize healthcare with real-time data.The importance of clinical validation in health tech.User experience is crucial for technology adoption.The vision for Profusa has remained consistent over the years.Data must be meaningful for healthcare decisions.The company focuses on chronic disease management.Future products will expand beyond glucose monitoring.Accessibility of technology is a key mission for Profusa.DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode I interview JW Roth, CEO and founder of Venu Holding Corporation, shares his journey from being a police officer to becoming an entrepreneur in the entertainment and hospitality industry. He discusses the innovative business model of fractional ownership in music venues, the importance of creating a premium experience for concert-goers, and the expansion of his company into hospitality services. Roth emphasizes his passion for live music and his commitment to building venues that cater to fans' needs, ultimately aiming to disrupt the traditional concert experience.Venu Website https://venu.live/Nano Cap Podcast Website https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Thomas Gaffney, COO of OFA Group, shares his unique journey from law school to the business world, emphasizing the importance of merging architecture with AI technology. He discusses his experiences in China, the challenges of transitioning from law to business, and the innovative tools OFA Group is developing to streamline architectural compliance. Gaffney also outlines the company's vision for expansion and the future of their AI-driven products, highlighting the significance of compliance in architecture and the role of teamwork in achieving their goals.OFA Group Website: https://www.ofacorp.com/Nano Cap Podcast Website: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this Episode, Joel Latham, CEO of Incannex Healthcare, discusses his career journey, the innovative approaches of Incannex Healthcare in drug development, particularly focusing on combination therapies involving cannabinoids and psychedelics. He highlights the company's unique solutions for obstructive sleep apnea and other chronic conditions, emphasizing the importance of patient-centric approaches and the potential for significant market impact. Latham also shares insights into the future vision of Incannex Healthcare and the expected advancements in their lead assets.INCANNEX WEBSITE: https://incannex.com/NANO CAP PODCAST WEBSITE: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Kimball Carr, CEO of Inspire Veterinary Partners, shares his journey into the veterinary industry, the founding of Inspire, and the company's unique approach to veterinary care. He discusses the long-term vision for the company, the importance of maintaining local identities for acquired clinics, and the strategies for growth and acquisition in the veterinary market. Kimball emphasizes the significance of community engagement, equity sharing for veterinary professionals, and the evolving landscape of pet care, including equine services. He also outlines the key performance indicators that drive the company's success and the exciting future ahead for Inspire Veterinary Partners.TakeawaysKimball Carr transitioned from consumer products to veterinary care.Inspire Veterinary Partners aims for long-term community engagement.The company focuses on equity sharing for veterinary professionals.Maintaining local branding is crucial for acquired clinics.The veterinary market is experiencing consistent growth.Acquisition strategy includes looking for cultural fit and quality medicine.Inspire is exploring technology and distribution for future growth.The equine veterinary market presents unique opportunities.Key performance indicators include visits and average patient charges.The next five years will see significant expansion for Inspire.Inspire Veterinary Partners Website https://www.inspirevet.com/Nano Cap Podcast Website https://www.nanocappod.com/Disclaimer:The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Mark Porter, CEO of Highwire Networks (HWNI), shares his journey from police officer to telecom executive to leading a cutting-edge cybersecurity platform. He discusses how Highwire has transitioned from deploying network infrastructure to managing complex cybersecurity ecosystems tailored to evolving threats. Mark explains how their approach to cybersecurity focuses on operationalizing data and providing seamless solutions for clients and partners. The conversation also highlights how shifting buyer expectations, AI, and vendor-agnostic strategies are shaping Highwire’s future.High Wire Networks Website https://www.highwirenetworks.com/Nano Cap Podcast Websitehttps://www.nanocappod.com/Disclaimer:The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this podcast episode, Chris Gannon, CEO of 374Water, discusses his transition from private equity to leading a company focused on innovative water purification technology. He explains the unique capabilities of 374Water's AirSCWO technology, which effectively destroys hazardous and non-hazardous organic waste while producing safe water and energy. Gannon highlights the growing concern over forever chemicals and the company's commitment to addressing this issue through education and advocacy. He outlines the market opportunities for 374Water, including partnerships with government and industrial sectors, and shares his vision for the company's future growth and international expansion.374Water Website https://374water.com/Nano Cap Podcast Website https://www.nanocappod.com/Disclaimer:The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Claude Zdanow shares his journey from aspiring rock star to successful entrepreneur in the marketing industry. He discusses his early experiences in music, the transition to running a recording studio, and the founding of ONAR, a marketing conglomerate. Zdanow emphasizes the importance of leveraging technology and AI in marketing strategies, the potential for growth in the industry, and the vision for ONAR as a public company. He highlights the need for innovative approaches to meet the demands of middle-market businesses and the exciting opportunities that lie ahead.ONAR website: https://www.onar.com/Nano Cap Podcast: https://www.nanocappod.com/

In this conversation, John Lai, CEO of Petvivo, shares his journey from the oil industry to leading a biomedical company focused on innovative therapies for companion animals. He discusses the challenges and insights gained from his previous experiences, the unique technologies developed at Petvivo, and the importance of understanding market dynamics in veterinary care. John emphasizes the company's commitment to improving the quality of life for pets through groundbreaking products and the potential for growth in the pet healthcare market.Petvivo Website https://www.petvivo.com/Nano Cap Podcast Website https://www.nanocappod.com/

In this episode, Jarrett Boon, founder and CEO of Safety Shot, shares his entrepreneurial journey from the vacation lead industry to creating a beverage that helps detoxify alcohol effects. He discusses the challenges and innovations behind Safety Shot, a clinically proven drink designed to lower blood alcohol content and mitigate negative effects of alcohol consumption. Jared also outlines the strategic decisions made in marketing and distribution, emphasizing the importance of online presence and consumer education. Looking ahead, he shares plans for product refinement and expansion into wellness products.Sure Shot Website https://sureshot.com/Safety Shot Website https://safetyshotofficial.com/Nano Cap Podcast https://www.nanocappod.com/

In this conversation, Chris Ehrlich, CEO of CERo Therapeutics, shares his extensive experience in the biotech industry, particularly in cancer treatment and immunotherapy. He discusses the challenges and opportunities within the biotech landscape, including the process of going public, valuations, and the unique aspects of developing T-cell therapeutics. Chris emphasizes the importance of innovation in cancer treatment and outlines the future aspirations for CERo Therapeutics as they move towards clinical trials.CERo Therapeutics Website https://www.cero.bio/Nano Cap Podcast Website https://www.nanocappod.com/

In this episode, Dr. Marc Hedrick, CEO of Plus Therapeutics, shares his journey from academia to the biotech industry, discussing the innovative work being done in targeted radiotherapeutics for difficult-to-treat cancers. He elaborates on the importance of diagnostics in cancer treatment, the challenges of navigating the FDA approval process, and the complexities of scaling and manufacturing radiotherapeutic drugs. Dr. Hedrick also reflects on his motivations and the potential impact of their work on patient lives.Plus Therapeutics Website https://plustherapeutics.com/Nano Cap Podcast Website https://www.nanocappod.com/

In this conversation, I speak with Ilan Sobol, CEO of Bio Harvest Sciences, who shares his diverse background and journey from South Africa to leading a biotech company focused on plant cell technology. He discusses the importance of cultural insights, the entrepreneurial spirit, and the scientific innovations driving Bio Harvest's success. The conversation also delves into market strategies, the balance between educating consumers and scaling production, and the critical feedback loop from customers that informs research and development.Bioharvest’s Website https://bioharvest.com/Nano Cap Podcast Website https://www.nanocappod.com/

In this episode, Paul Romness, CEO of OSTherapies, discusses his journey in the biotech industry, the challenges and breakthroughs in developing treatments for osteosarcoma, and the innovative approaches his company is taking to enhance cancer therapies. He emphasizes the importance of collaboration, the potential market for their treatments, and the unique relationship between canine and human osteosarcoma. The conversation also touches on the financial aspects of running a biotech company and the regulatory landscape they navigate as a public company.OS Therapies Website https://ostherapies.com/Nano Cap Podcast Website https://www.nanocappod.com/

In this episode, David Vanderveen, president of Prenetics, shares his journey from the beverage industry to leading a health science company. He discusses the success of XS Energy Drinks, the benefits of distribution through Amway, and the innovative direction Prenetics is taking in genomics and consumer health. With a focus on scientific backing and consumer engagement, Prenetics aims to revolutionize health and wellness products, leveraging partnerships and cutting-edge research.

In this week's episode, I talk to Dave Rosa, the president and CEO of NeuroOne Medical Technologies. We discuss Dave's journey into the medical device industry, the innovative technologies NeuroOne is developing for neurological disorders, particularly epilepsy, and the strategic partnerships that are shaping the company's future. Dave shares insights on the challenges of going public and the company's focus on pain management solutions, emphasizing the importance of minimizing patient invasiveness and maximizing therapeutic outcomes.NeuroOne's Websitehttps://nmtc1.com/To keep in touchhttps://www.nanocappod.com/

In this week's episode, Kit Gray, CEO of PodcastOne, shares his journey from various roles in media to leading a prominent podcasting network. He discusses the evolution of podcasting, its impact on advertising, and the challenges faced in the industry. Kit emphasizes the importance of community and engagement in podcasting, the unique business model of PodcastOne, and the future of the medium as it continues to grow and adapt. PodcastOne Website https://www.podcastone.com/ Nano Cap Podcast Website https://www.nanocappod.com/

In this conversation, Paul Allen, president of Airship AI, shares his journey from military service to corporate leadership, discussing the evolution of Airship AI and its focus on AI-driven video surveillance technology. He emphasizes the importance of realistic expectations in leadership, the role of partnerships in technology development, and the various applications of their products in both government and commercial sectors. Paul also addresses the impact of political changes on business strategy and outlines his vision for the future of Airship AI, highlighting the need for innovation and adaptation in a rapidly evolving technological landscape. Airship Website https://airship.ai/ Nano Cap Podcast Website https://www.nanocappod.com/

In this week’s episode, I interview Joe Davy, CEO of Banzai International. He shares his journey from software engineer to leading a marketing technology company. He discusses the challenges in the marketing landscape, particularly the fragmentation of tools and the need for integration. Joe explains how Banzai was founded to address these issues, focusing on demand generation and automation. He reflects on the company's growth, the importance of finding product-market fit, and the vision for the future of marketing technology. In this conversation, Joe Davy discusses his journey with startups, the challenges of going public, and the lessons learned from his experience at Avalara. He emphasizes the importance of resilience in business, the role of AI in marketing, and how automation can transform traditional marketing processes. Davy also addresses the balance between costs and value in AI solutions, highlighting the potential for margin expansion in the future.

In this episode, Desmond Wheatley, CEO of Beam Global, discusses the company's innovative approach to electric vehicle charging infrastructure and sustainable energy solutions. He shares his background, the vision behind Beam Global, and the unique products they offer, including the EV-ARC. Desmond also highlights the challenges of navigating government contracts, the importance of local sourcing, and his vision for the future of energy solutions, emphasizing the need for rapid deployment and scalability in urban environments. Beam Globals Website https://beamforall.com/

In this episode, Simon Szewach, the executive chairman and co-founder of Gelteq, discusses the innovative gel-based medications and nutraceuticals developed by his company. He shares insights into the journey of Gelteq from its inception in Australia to becoming a public company in the US, highlighting the unique advantages of gel technology in delivering medications, especially for those with swallowing difficulties. Simon also elaborates on the company's focus on both human and pet health, the regulatory landscape, and the future growth prospects of Gelteq in the pharmaceutical industry.

In this episode, Scott Wallace, co-founder and CEO of ECD Automotive Design, shares his journey from a gearhead with a passion for cars to leading a company that disrupts the luxury automotive space. He discusses the importance of client-centric customization, the challenges of scaling beyond traditional mom-and-pop shops, and the allure of Land Rovers as a luxury product. Scott also elaborates on the company's expansion strategies, the decision to go public, and the vision for creating a unique luxury retail experience. ECD Automotive Design Website

In this podcast episode, Will Tjernlund interviews Lew Bender, the President and CEO of Intensity Therapeutics, a biotech company focused on developing innovative cancer treatments. Lew shares his academic journey from a working-class background to prestigious institutions like MIT and Wharton, and discusses his career in biotech, leading to the creation of a novel drug delivery system that targets tumors directly. He emphasizes the importance of personalized medicine and the potential of his company's approach to improve patient outcomes while minimizing side effects. Lew's personal experiences with cancer in his family drive his passion for this work, and he expresses a commitment to helping as many patients as possible.Nano Cap Podcast Website: https://www.nanocappod.com/Intensity Therapeutics Website: https://intensitytherapeutics.com/Disclaimer:The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund interviews John Yu, CEO of Kairos Pharma, who shares his journey from medical school to leading a biotech company focused on reversing cancer drug resistance. John discusses the innovative therapies being developed at Kairos Pharma, the importance of personalized medicine, and the challenges of navigating FDA approval processes. He also reflects on the future of the company and the broader impact of their work in the field of immunology and cancer treatment. Kairos Pharma Website

In this conversation, Jim Martin, CEO of Cocrystal Pharma, discusses his journey from a career in finance to leading a biotechnology company focused on developing antiviral treatments. He explains the unique challenges of the biotech industry, particularly the importance of efficiency and cost management in drug development. He also shares insights into the FDA approval process and the strategic decisions involved in bringing new therapeutics to market.

In this episode, Will Tjernlund interviews Brent Lucas, CEO of Envoy Medical, who shares his unique journey from law school to leading a medical device company focused on innovative hearing solutions. Brent discusses the challenges and opportunities in the cochlear implant market, the importance of insurance reimbursement, and the future vision for Envoy Medical as they aim to disrupt the industry with their groundbreaking products.Envoy Medical WebsiteTakeawaysBrent Lucas has a non-traditional journey to CEO, having worked in various roles at Envoy Medical.Envoy Medical focuses on innovative hearing solutions beyond traditional hearing aids.The company was founded on the idea of using the ear to pick up sound, not a microphone.Envoy's first product, the Esteem, faced challenges due to lack of insurance reimbursement.The Acclaim cochlear implant is currently in early feasibility studies at Mayo Clinic.Brent emphasizes the importance of being part of the medical device community in Minnesota.The company aims to disrupt existing cochlear implant market leaders.Brent relies on a strong engineering team and external advisors for technical guidance.The future focus includes expanding product offerings and improving insurance coverage for existing products.Brent believes steady progress is key to success in the medical device industry.

In this episode, I speak with Brenner Adams, Chief Growth Officer of TruGolf, about the evolution of golf simulation technology and the company's journey from video gaming to creating immersive golf experiences. Brenner shares insights from his career, the technological advancements that have shaped TruGolf's products, and the future of golf as a sport. The conversation highlights the importance of data analytics in improving golf skills and the company's vision to make golf more accessible to a wider audience. TruGolf Website

In this episode, I interview Kathy Lee-Sepsik, CEO of Femasys, a biotech company focused on women's health. Kathy shares her journey from a background in med tech to founding Femasys, driven by a personal desire to innovate in women's healthcare. The conversation explores Femasys's unique product offerings, including solutions for infertility and non-surgical birth control, and discusses the current landscape of women's health, regulatory challenges, and market demand. Kathy emphasizes the importance of addressing women's health needs and the potential for Femasys to lead in this underfunded area.Femasys https://www.femasys.com/

In this week's episode, I have the pleasure of speaking with Josh Sodaitis, the CEO of Peer To Peer Network. Stock ticker PTOP. Peer To Peer Network’s main product is MobiCard, An Exclusive And Revolutionary Digital Business Card Platform Exchange For Seamless Networking. Download the MobiCard App HERE Peer To Peer Network Website